BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 15899793)

  • 21. ESX induces transformation and functional epithelial to mesenchymal transition in MCF-12A mammary epithelial cells.
    Schedin PJ; Eckel-Mahan KL; McDaniel SM; Prescott JD; Brodsky KS; Tentler JJ; Gutierrez-Hartmann A
    Oncogene; 2004 Mar; 23(9):1766-79. PubMed ID: 14767472
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Caveolin-1 inhibits the growth of human laryngeal squamous cell carcinoma and down regulates EGFR-MAPKs signaling pathway.
    Gu D; Li H; Wang Z; Chen Q; Jiang J; Zhu H
    Laryngoscope; 2007 Oct; 117(10):1782-9. PubMed ID: 17906498
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hath1, down-regulated in colon adenocarcinomas, inhibits proliferation and tumorigenesis of colon cancer cells.
    Leow CC; Romero MS; Ross S; Polakis P; Gao WQ
    Cancer Res; 2004 Sep; 64(17):6050-7. PubMed ID: 15342386
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel protein tyrosine kinase NOK that shares homology with platelet- derived growth factor/fibroblast growth factor receptors induces tumorigenesis and metastasis in nude mice.
    Liu L; Yu XZ; Li TS; Song LX; Chen PL; Suo TL; Li YH; Wang SD; Chen Y; Ren YM; Zhang SP; Chang ZJ; Fu XY
    Cancer Res; 2004 May; 64(10):3491-9. PubMed ID: 15150103
    [TBL] [Abstract][Full Text] [Related]  

  • 25. c-Jun NH(2)-terminal kinase 2alpha2 promotes the tumorigenicity of human glioblastoma cells.
    Cui J; Han SY; Wang C; Su W; Harshyne L; Holgado-Madruga M; Wong AJ
    Cancer Res; 2006 Oct; 66(20):10024-31. PubMed ID: 17047065
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MAPK/AP-1 signal pathway in tobacco smoke-induced cell proliferation and squamous metaplasia in the lungs of rats.
    Zhong CY; Zhou YM; Douglas GC; Witschi H; Pinkerton KE
    Carcinogenesis; 2005 Dec; 26(12):2187-95. PubMed ID: 16051644
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Visfatin activates eNOS via Akt and MAP kinases and improves endothelial cell function and angiogenesis in vitro and in vivo: translational implications for atherosclerosis.
    Lovren F; Pan Y; Shukla PC; Quan A; Teoh H; Szmitko PE; Peterson MD; Gupta M; Al-Omran M; Verma S
    Am J Physiol Endocrinol Metab; 2009 Jun; 296(6):E1440-9. PubMed ID: 19351806
    [TBL] [Abstract][Full Text] [Related]  

  • 28. p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis.
    Cabodi S; Tinnirello A; Di Stefano P; BisarĂ² B; Ambrosino E; Castellano I; Sapino A; Arisio R; Cavallo F; Forni G; Glukhova M; Silengo L; Altruda F; Turco E; Tarone G; Defilippi P
    Cancer Res; 2006 May; 66(9):4672-80. PubMed ID: 16651418
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transcriptional repression by the basic helix-loop-helix protein Dec2: multiple mechanisms through E-box elements.
    Fujimoto K; Hamaguchi H; Hashiba T; Nakamura T; Kawamoto T; Sato F; Noshiro M; Bhawal UK; Suardita K; Kato Y
    Int J Mol Med; 2007 Jun; 19(6):925-32. PubMed ID: 17487425
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of hypoxia-related gene expression in sarcomas and effect of hypoxia on RNA interference of vascular endothelial cell growth factor A.
    Detwiller KY; Fernando NT; Segal NH; Ryeom SW; D'Amore PA; Yoon SS
    Cancer Res; 2005 Jul; 65(13):5881-9. PubMed ID: 15994966
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Proline-rich tyrosine kinase 2 (Pyk2) promotes proliferation and invasiveness of hepatocellular carcinoma cells through c-Src/ERK activation.
    Sun CK; Man K; Ng KT; Ho JW; Lim ZX; Cheng Q; Lo CM; Poon RT; Fan ST
    Carcinogenesis; 2008 Nov; 29(11):2096-105. PubMed ID: 18765415
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bidirectional signals transduced by TOPK-ERK interaction increase tumorigenesis of HCT116 colorectal cancer cells.
    Zhu F; Zykova TA; Kang BS; Wang Z; Ebeling MC; Abe Y; Ma WY; Bode AM; Dong Z
    Gastroenterology; 2007 Jul; 133(1):219-31. PubMed ID: 17631144
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low molecular weight inhibitors of Myc-Max interaction and function.
    Yin X; Giap C; Lazo JS; Prochownik EV
    Oncogene; 2003 Sep; 22(40):6151-9. PubMed ID: 13679853
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The scatter factor/hepatocyte growth factor: c-met pathway in human embryonal central nervous system tumor malignancy.
    Li Y; Lal B; Kwon S; Fan X; Saldanha U; Reznik TE; Kuchner EB; Eberhart C; Laterra J; Abounader R
    Cancer Res; 2005 Oct; 65(20):9355-62. PubMed ID: 16230398
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functions of myc:max in the control of cell proliferation and tumorigenesis.
    Hurlin PJ; Dezfouli S
    Int Rev Cytol; 2004; 238():183-226. PubMed ID: 15364199
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 15-deoxy-Delta12,14 prostaglandin J2 up-regulates Kruppel-like factor 4 expression independently of peroxisome proliferator-activated receptor gamma by activating the mitogen-activated protein kinase kinase/extracellular signal-regulated kinase signal transduction pathway in HT-29 colon cancer cells.
    Chen ZY; Tseng CC
    Mol Pharmacol; 2005 Nov; 68(5):1203-13. PubMed ID: 16077033
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The proto-oncoprotein c-Fos negatively regulates hepatocellular tumorigenesis.
    Mikula M; Gotzmann J; Fischer AN; Wolschek MF; Thallinger C; Schulte-Hermann R; Beug H; Mikulits W
    Oncogene; 2003 Oct; 22(43):6725-38. PubMed ID: 14555986
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gene-target recognition among members of the myc superfamily and implications for oncogenesis.
    O'Hagan RC; Schreiber-Agus N; Chen K; David G; Engelman JA; Schwab R; Alland L; Thomson C; Ronning DR; Sacchettini JC; Meltzer P; DePinho RA
    Nat Genet; 2000 Feb; 24(2):113-9. PubMed ID: 10655054
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activation of MAPK signaling pathway is essential for Id-1 induced serum independent prostate cancer cell growth.
    Ling MT; Wang X; Ouyang XS; Lee TK; Fan TY; Xu K; Tsao SW; Wong YC
    Oncogene; 2002 Dec; 21(55):8498-505. PubMed ID: 12466969
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumor promoting properties of the ETS protein MEF in ovarian cancer.
    Yao JJ; Liu Y; Lacorazza HD; Soslow RA; Scandura JM; Nimer SD; Hedvat CV
    Oncogene; 2007 Jun; 26(27):4032-7. PubMed ID: 17213815
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.